Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Growth hormone therapy in the Prader-Willi syndrome.

× No keyword cloud information.

21 in total

Review 1. Prader-Willi and Angelman syndromes. Disorders of genomic imprinting.

Authors: S B Cassidy; S Schwartz
Journal: Medicine (Baltimore) Date: 1998-03 Impact factor: 1.889

2. Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.

Authors: G Grugni; G Guzzaloni; F Morabito
Journal: J Endocrinol Invest Date: 2001-05 Impact factor: 4.256

3. Energy expenditure and body composition in Prader-Willi syndrome.

Authors: D A Schoeller; L L Levitsky; L G Bandini; W W Dietz; A Walczak
Journal: Metabolism Date: 1988-02 Impact factor: 8.694

4. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction.

Authors: J Argente; N Caballo; V Barrios; J Pozo; M T Muñoz; J A Chowen; M Hernández
Journal: J Clin Endocrinol Metab Date: 1997-07 Impact factor: 5.958

5. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.

Authors: M Angulo; M Castro-Magana; B Mazur; J A Canas; P M Vitollo; M Sarrantonio
Journal: J Pediatr Endocrinol Metab Date: 1996 May-Jun Impact factor: 1.634

Review 6. The Prader-Willi syndrome.

Authors: M D Donaldson; C E Chu; A Cooke; A Wilson; S A Greene; J B Stephenson
Journal: Arch Dis Child Date: 1994-01 Impact factor: 3.791

1. [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy].

Authors: Constanze Lämmer; Edda Weimann
Journal: Wien Med Wochenschr Date: 2007-02

2. Clinical implications of gait analysis in the rehabilitation of adult patients with "Prader-Willi" Syndrome: a cross-sectional comparative study ("Prader-Willi" Syndrome vs matched obese patients and healthy subjects).

Authors: Luca Vismara; Marianna Romei; Manuela Galli; Angelo Montesano; Gabriele Baccalaro; Marcello Crivellini; Graziano Grugni
Journal: J Neuroeng Rehabil Date: 2007-05-10 Impact factor: 4.262

2 in total

Growth hormone therapy in the Prader-Willi syndrome.

Review 1. Prader-Willi and Angelman syndromes. Disorders of genomic imprinting.

2. Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.

3. Energy expenditure and body composition in Prader-Willi syndrome.

4. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction.

5. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.

Review 6. The Prader-Willi syndrome.

7. Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children.

8. Peculiar body composition in patients with Prader-Labhart-Willi syndrome.

9. Standards for selected anthropometric measurements in Prader-Willi syndrome.

10. MR of the pituitary in patients with Prader-Willi syndrome: size determination and imaging findings.

1. [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy].

2. Clinical implications of gait analysis in the rehabilitation of adult patients with "Prader-Willi" Syndrome: a cross-sectional comparative study ("Prader-Willi" Syndrome vs matched obese patients and healthy subjects).